相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Marwan K. Tayeh et al.
GENETICS IN MEDICINE (2022)
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L. Beitelshees et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Pharmacogenetics at Scale: An Analysis of the UK Biobank
Gregory McInnes et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese
Chun-Yu Wei et al.
NPJ GENOMIC MEDICINE (2021)
Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000-2020)
Jeeyun A. Kim et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals
Yang Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Pharmacogenetics to guide cardiovascular drug therapy
Julio D. Duarte et al.
NATURE REVIEWS CARDIOLOGY (2021)
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
Michelle Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Comparison of multiple imputation algorithms and verification using whole-genome sequencing in the CMUH genetic biobank
Ting-Yuan Liu et al.
BIOMEDICINE-TAIWAN (2021)
Pharmacogenomics Clinical Annotation Tool (PharmCAT)
Katrin Sangkuhl et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
A high-resolution HLA imputation system for the Taiwanese population: a study of the Taiwan Biobank
Yu-Han Huang et al.
PHARMACOGENOMICS JOURNAL (2020)
A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus onCYP2D6genotyping
David Twesigomwe et al.
NPJ GENOMIC MEDICINE (2020)
A Review of the Important Role of CYP2D6 in Pharmacogenomics
Christopher Taylor et al.
GENES (2020)
Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation
John Mauleekoonphairoj et al.
SCIENTIFIC REPORTS (2020)
Stargazer: a software tool for calling star alleles from nextgeneration sequencing data using CYP2D6 as a model
Seung-been Lee et al.
GENETICS IN MEDICINE (2019)
Pharmacogenomics and big genomic data: from lab to clinic and back again
Adam Lavertu et al.
HUMAN MOLECULAR GENETICS (2018)
Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes
Ibrahim Numanagic et al.
NATURE COMMUNICATIONS (2018)
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L. V. Kalman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
CYP2D6 copy number distribution in the US population
Michelle Beoris et al.
PHARMACOGENETICS AND GENOMICS (2016)
Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences
Greyson P. Twist et al.
NPJ GENOMIC MEDICINE (2016)
Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies
Shigeo Kamitsuji et al.
JOURNAL OF HUMAN GENETICS (2015)
Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data
Matthias Samwald et al.
PHARMACOGENOMICS (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
Hiromichi Maeda et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
HIBAG-HLA genotype imputation with attribute bagging
X. Zheng et al.
PHARMACOGENOMICS JOURNAL (2014)
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Clopidogrel pathway
Katrin Sangkuhl et al.
PHARMACOGENETICS AND GENOMICS (2010)
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
Christoph Varenhorst et al.
EUROPEAN HEART JOURNAL (2009)
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
J. T. Brandt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications
A Premawardhena et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
分享论文
